Thiazide and thiazide-like diuretics: An opportunity to reduce blood pressure in patients with advanced kidney disease

Current Hypertension Reports

Volumn 14, Issue 5, 2012, Pages 416-420

  Karadsheh, Feras ^a   Weir, Matthew R ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Antihypertensive drug therapy; Blood pressure; Chronic kidney disease; CKD; GFR; Glomerular filtration rate; Hypertension; Loop diuretics; Thiazide; Thiazide like diuretics

Indexed keywords

BENDROFLUMETHIAZIDE; CHLORTALIDONE; DIURETIC AGENT; ENALAPRIL; FUROSEMIDE; HYDROCHLOROTHIAZIDE; PLACEBO; SODIUM; SODIUM CHLORIDE COTRANSPORTER; THIAZIDE DIURETIC AGENT;

ANTIHYPERTENSIVE ACTIVITY; BLOOD PRESSURE REGULATION; CHRONIC KIDNEY DISEASE; DIURESIS; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG DOSE COMPARISON; DRUG DOSE REDUCTION; DRUG HALF LIFE; DRUG POTENCY; DRUG UTILIZATION; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; MEDICAL DECISION MAKING; META ANALYSIS (TOPIC); NATRIURESIS; NONHUMAN; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; TREATMENT OUTCOME; VASODILATATION;

ANTIHYPERTENSIVE AGENTS; CHLORTHALIDONE; GLOMERULAR FILTRATION RATE; HUMANS; HYDROCHLOROTHIAZIDE; HYPERTENSION; RENAL INSUFFICIENCY, CHRONIC; SODIUM CHLORIDE SYMPORTER INHIBITORS; SODIUM POTASSIUM CHLORIDE SYMPORTER INHIBITORS; TREATMENT OUTCOME;

EID: 84870486250     PISSN: 15226417     EISSN: 15343111     Source Type: Journal    
DOI: 10.1007/s11906-012-0293-4     Document Type: Review

References (40)

1. Hollander W, Wilkins RW. Chlorothiazide: a new type of drug for the treatment of arterial hypertension. BMQ. 1957;8(3):69-75.
2. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group. JAMA 1991; 265(24):3255-3264.
3. Cutler JA, MacMahon SW, Furberg CD. Controlled clinical trials of drug treatment for hypertension. A review. Hypertension. 1989;13(5 Suppl):I36-44.
4. Psaty BM, Smith NL, Siscovick DS, Koepsell TD, Weiss NS, Heckbert SR, et al. Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis. JAMA. 1997;277(9):739-45.
5. Collins R, Peto R, Godwin J, MacMahon S. Blood pressure and coronary heart disease. Lancet. 1990;336(8711):370-1.
6. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002; 288(23):2981-2997.
7. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo Jr. JL, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42(6):1206-52.
8. Schreiner GE. Chlorothiazide in renal disease. Ann N YAcad Sci. 1958;71(4):420-9.
9. Reubi FC, Cottier PT. Effects of reduced glomerular filtration rate on responsiveness to chlorothiazide and mercurial diuretics. Circulation. 1961;23:200-10.
10. Duarte JD, Cooper-DeHoff RM. Mechanisms for blood pressure lowering and metabolic effects of thiazide and thiazide-like diuretics. Expert Rev Cardiovasc Ther. 2010;8(6):793-802.
11. Ellison DH, Velazquez H, Wright FS. Thiazide-sensitive sodium chloride cotransport in early distal tubule. Am J Physiol. 1987;253 (3 Pt 2):F546-54.
12. Eladari D, Chambrey R. Identification of a novel target of thiazide diuretics. J Nephrol. 2011;24(4):391-4.
13. Pickkers P, Hughes AD, Russel FG, Thien T, Smits P. Thiazideinduced vasodilation in humans is mediated by potassium channel activation. Hypertension. 1998;32(6):1071-6.
14. Carter BL, Ernst ME, Cohen JD. Hydrochlorothiazide versus chlorthalidone: evidence supporting their interchangeability. Hypertension. 2004;43(1):4-9.
15. Allen JH, McKenney JM, Stratton MA, Link K. Antihypertensive effect of hydrochlorothiazide administered once or twice daily. Clin Pharm. 1982;1(3):239-43.
16. De Plaen JF, Vander EE, Van de Ypersele SC. Penbutolol or hydrochlorothiazide once a day in hypertension. A controlled study with home measurements. Br J Clin Pharmacol. 1981;12 (2):215-21.
17. Cushman WC, Khatri I, Materson BJ, Reda DJ, Freis ED, Goldstein G, et al. Treatment of hypertension in the elderly. III. Response of isolated systolic hypertension to various doses of hydrochlorothiazide: results of a Department of Veterans Affairs cooperative study. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. Arch Intern Med. 1991;151(10):1954-60.
18. Kohvakka A, Salo H, Gordin A, Eisalo A. Antihypertensive and biochemical effects of different doses of hydrochlorothiazide alone or in combination with triamterene. Acta Med Scand. 1986;219 (4):381-6.
19. Peterzan MA, Hardy R, Chaturvedi N, Hughes AD. Meta-Analysis of Dose-Response Relationships for Hydrochlorothiazide, Chlorthalidone, and Bendroflumethiazide on Blood Pressure, Serum Potassium, and Urate. Hypertension 2012. This meta-analysis is one of a few that compared head to head three of the most widely used thiazide and thiazide-like diuretics, studied their potency and efficacy profiles, and presented evidence that thiazide and thiazide-like diuretics have different potencies but they all share similar side effect and efficacy profiles.
20. Bengtsson C, Johnsson G, Sannerstedt R, Werko L. Effect of different doses of chlorthalidone on blood pressure, serum potassium, and serum urate. Br Med J. 1975;1(5951):197-9.
21. Grimm Jr. RH, Neaton JD, McDonald M, Case J, McGill E, Allen R, et al. Beneficial effects from systematic dosage reduction of the diuretic, chlorthalidone: a randomized study within a clinical trial. Am Heart J. 1985;109(4):858-64.
22. van BP, Man in 't Veld AJ, Schalekamp MA. Hemodynamic changes during long-term thiazide treatment of essential hypertension in responders and nonresponders. Clin Pharmacol Ther 1980; 27(3):328-336.
23. Materson BJ, Oster JR, Michael UF, Bolton SM, Burton ZC, Stambaugh JE, et al. Dose response to chlorthalidone in patients with mild hypertension. Efficacy of a lower dose. Clin Pharmacol Ther. 1978;24(2):192-8.
24. Wing LM, Reid CM, Ryan P, Beilin LJ, Brown MA, Jennings GL, et al. Second Australian National Blood Pressure Study (ANBP2). Australian Comparative Outcome Trial of ACE inhibitor-and diuretic-based treatment of hypertension in the elderly. Management Committee on behalf of the High Blood Pressure Research Council of Australia. Clin Exp Hypertens. 1997;19(5-6):779-91.
25. Dorsch MP, Gillespie BW, Erickson SR, Bleske BE, Weder AB. Chlorthalidone reduces cardiovascular events compared with hydrochlorothiazide: a retrospective cohort analysis. Hypertension. 2011;57(4):689-94.
26. Conway J, Lauwers P. Hemodynamic and hypotensive effects of long-term therapy with chlorothiazide. Circulation. 1960;21:21-7.
27. Wilson IM, Freis ED. Relationship between plasma and extracellular fluid volume depletion and the antihypertensive effect of chlorothiazide. Circulation. 1959;20:1028-36.
28. Winer BM. The antihypertensive actions of benzothiadiazines. Circulation. 1961;23:211-8.
29. Aleksandrow D, Wysznacka W, Gajewski J. Influence of chlorothiazide upon arterial responsiveness to nor-epinephrine in hypertensive subjects. N Engl J Med. 1959;261:1052-5.
30. Freis ED, Wanko A, Schnaper HW, Forhlich ED. Mechanism of the altered blood pressure responsiveness produced by chlorothiazide. J Clin Invest. 1960;39:1277-81.
31. Zhu Z, Zhu S, Liu D, Cao T, Wang L, Tepel M. Thiazide-like diuretics attenuate agonist-induced vasoconstriction by calcium desensitization linked to Rho kinase. Hypertension. 2005;45 (2):233-9.
32. Colas B, Slama M, Collin T, Safar M, Andrejak M. Mechanisms of methyclothiazide-induced inhibition of contractile responses in rat aorta. Eur J Pharmacol. 2000;408(1):63-7.
33. Hughes AD. How do thiazide and thiazide-like diuretics lower blood pressure? J Renin Angiotensin Aldosterone Syst. 2004;5(4):155-60.
34. Pickkers P, Hughes AD, Russel FG, Thien T, Smits P. In vivo evidence for K(Ca) channel opening properties of acetazolamide in the human vasculature. Br J Pharmacol. 2001;132(2):443-50.
35. Dussol B, Moussi-Frances J, Morange S, Somma-Delpero C, Mundler O, Berland Y. A pilot study comparing furosemide and hydrochlorothiazide in patients with hypertension and stage 4 or 5 chronic kidney disease. J Clin Hypertens (Greenwich). 2012;14 (1):32-7. This pilot randomized controlled study presents strong evidence that thiazides, represented here by hydrochlorothiazide, effectively lower blood pressure in patients with advanced kidney disease.
36. Jones B, Nanra RS. Double-blind trial of antihypertensive effect of chlorothiazide in severe renal failure. Lancet. 1979;2(8155):1258-60.
37. Tobian L. Why do thiazide diuretics lower blood pressure in essential hypertension? Annu Rev Pharmacol. 1967;7:399-408.
38. Dussol B, Moussi-Frances J, Morange S, Somma-Delpero C, Mundler O, Berland Y. A randomized trial of furosemide vs hydrochlorothiazide in patients with chronic renal failure and hypertension. Nephrol Dial Transplant. 2005;20(2):349-53.
39. Knauf H, Mutschler E. Diuretic effectiveness of hydrochlorothiazide and furosemide alone and in combination in chronic renal failure. J Cardiovasc Pharmacol. 1995;26(3):394-400.
40. Bricker NS, Fine LG, Kaplan M, Epstein M, Bourgoignie JJ, Light A. "Magnification phenomenon" in chronic renal disease. N Engl J Med. 1978;299(23):1287-93.